Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrothorax | 4 | 2023 | 4 | 3.310 |
Why?
|
| Liver Cirrhosis | 7 | 2023 | 160 | 2.000 |
Why?
|
| Liver Transplantation | 2 | 2023 | 189 | 1.460 |
Why?
|
| Hepatic Encephalopathy | 2 | 2023 | 8 | 0.970 |
Why?
|
| Hypertension, Portal | 2 | 2022 | 15 | 0.930 |
Why?
|
| Empyema | 1 | 2022 | 5 | 0.810 |
Why?
|
| Probiotics | 2 | 2015 | 41 | 0.610 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 70 | 0.470 |
Why?
|
| Retrospective Studies | 5 | 2023 | 5981 | 0.420 |
Why?
|
| Pancreatic Elastase | 1 | 2012 | 31 | 0.390 |
Why?
|
| Stents | 1 | 2015 | 436 | 0.390 |
Why?
|
| Serum | 1 | 2012 | 34 | 0.390 |
Why?
|
| Hepatitis C | 1 | 2013 | 139 | 0.380 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2012 | 63 | 0.360 |
Why?
|
| Hospital Mortality | 1 | 2015 | 842 | 0.360 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 855 | 0.320 |
Why?
|
| Leptin | 1 | 2006 | 78 | 0.260 |
Why?
|
| Hepatocytes | 2 | 2006 | 190 | 0.260 |
Why?
|
| Liver | 2 | 2006 | 785 | 0.240 |
Why?
|
| Apoptosis | 2 | 2006 | 1038 | 0.230 |
Why?
|
| Humans | 10 | 2023 | 59350 | 0.210 |
Why?
|
| Ascites | 1 | 2022 | 21 | 0.200 |
Why?
|
| Tertiary Care Centers | 1 | 2022 | 102 | 0.190 |
Why?
|
| Adult | 4 | 2023 | 15746 | 0.170 |
Why?
|
| Prognosis | 1 | 2023 | 1565 | 0.160 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 8 | 0.130 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2015 | 13 | 0.130 |
Why?
|
| Permeability | 1 | 2015 | 47 | 0.130 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2015 | 16 | 0.130 |
Why?
|
| Diarrhea | 1 | 2015 | 73 | 0.120 |
Why?
|
| Intestines | 1 | 2015 | 157 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 164 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2015 | 137 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 221 | 0.110 |
Why?
|
| Coronary Artery Bypass | 1 | 2015 | 273 | 0.110 |
Why?
|
| Treatment Outcome | 1 | 2023 | 5143 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 195 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2015 | 837 | 0.100 |
Why?
|
| Male | 4 | 2015 | 27526 | 0.100 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 695 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2015 | 2437 | 0.080 |
Why?
|
| Aged | 3 | 2015 | 13308 | 0.080 |
Why?
|
| Female | 4 | 2015 | 30845 | 0.080 |
Why?
|
| Obesity | 1 | 2015 | 1189 | 0.070 |
Why?
|
| Liver Failure, Acute | 1 | 2007 | 16 | 0.070 |
Why?
|
| Quinazolines | 1 | 2007 | 22 | 0.070 |
Why?
|
| Middle Aged | 2 | 2015 | 16254 | 0.070 |
Why?
|
| Thioacetamide | 1 | 2006 | 3 | 0.070 |
Why?
|
| Receptors, Leptin | 1 | 2006 | 12 | 0.070 |
Why?
|
| Fas Ligand Protein | 1 | 2006 | 39 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 607 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 169 | 0.070 |
Why?
|
| Egg Proteins | 1 | 2006 | 23 | 0.070 |
Why?
|
| Ovalbumin | 1 | 2006 | 114 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 177 | 0.060 |
Why?
|
| Actins | 1 | 2006 | 260 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 439 | 0.060 |
Why?
|
| United States | 1 | 2015 | 7495 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2006 | 3193 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2006 | 646 | 0.050 |
Why?
|
| Mice | 2 | 2006 | 10260 | 0.030 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2015 | 34 | 0.030 |
Why?
|
| Animals | 2 | 2006 | 19618 | 0.020 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2007 | 18 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2007 | 111 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 345 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2006 | 43 | 0.020 |
Why?
|
| Child | 1 | 2015 | 4300 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 135 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 145 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2006 | 165 | 0.020 |
Why?
|
| Ligands | 1 | 2006 | 422 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 274 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2006 | 353 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 671 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 740 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 1221 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 547 | 0.010 |
Why?
|